Seguir
Tejal Rawal
Tejal Rawal
PhD Research Scholar
Dirección de correo verificada de nirmauni.ac.in
Título
Citado por
Citado por
Año
Rifampicin loaded chitosan nanoparticle dry powder presents an improved therapeutic approach for alveolar tuberculosis
T Rawal, R Parmar, RK Tyagi, S Butani
Colloids and Surfaces B: Biointerfaces 154, 321-330, 2017
1392017
Chitosan nanoparticles as a promising approach for pulmonary delivery of bedaquiline
T Rawal, S Patel, S Butani
European Journal of Pharmaceutical Sciences 124, 273-287, 2018
682018
Combating tuberculosis infection: a forbidding challenge
T Rawal, S Butani
Indian journal of pharmaceutical sciences 78 (1), 8, 2016
342016
Prevalence of demodectic mange in canines of Kathmandu Valley having skin disorder and its associated risk factors
D Shrestha, B Thapa, G Rawal, S Dhakal, B Sharma
International Journal of Applied Sciences and Biotechnology 3 (3), 459-463, 2015
322015
Dry-powder inhaler formulation of rifampicin: an improved targeted delivery system for alveolar tuberculosis
T Rawal, L Kremer, I Halloum, S Butani
Journal of aerosol medicine and pulmonary drug delivery 30 (6), 388-398, 2017
272017
Chitosan Nanoparticles of Gamma-Oryzanol: Formulation, Optimization, and In vivo Evaluation of Anti-hyperlipidemic Activity
T Rawal, N Mishra, A Jha, A Bhatt, RK Tyagi, S Panchal, S Butani
Aaps Pharmscitech 19, 1894-1907, 2018
242018
Detection and cellular tropism of porcine astrovirus type 3 on breeding farms
G Rawal, FM Ferreyra, NR Macedo, LK Bradner, KM Harmon, A Mueller, ...
Viruses 11 (11), 1051, 2019
212019
Role of ayurveda in tumorigenesis: A brief review
T Sharma, G Rawal
International Journal of Green Pharmacy (IJGP) 6 (2), 2012
132012
Scoping review on the epidemiology, diagnostics and clinical significance of porcine astroviruses
G Rawal, DCL Linhares
Transboundary and Emerging Diseases 69 (3), 974-985, 2022
122022
Transdermal Therapeutic Systems, An overview
S Teja, R Gaurav
International Journal of Pharmaceutical & Biological Archives 2 (6), 1581-1587, 2011
112011
General overview of the detection of Mycoplasma hyopneumoniae DNA by quantitative polymerase chain reaction in diagnostic cases submitted to the Iowa State University …
G Rawal, P Arruda, C Rademacher, D Linhares, R Bi
92018
Basic Aspects of Process Validation of Solid Oral Dosage Forms
S Tejal
International Journal Pharmaceutical Erudition 1 (4), 1-15, 2012
62012
Process Validation: An Essentiality in the Pharmaceutical Industry
T Sharma, NS Solanki, OP Mahatma
International journal of pharmaceutical research and development 3 (10), 2011
62011
Porcine astrovirus type 3 is an emerging cause of atypical neurologic disease: Diagnostic cases and infection dynamics on affected flows
G Rawal, F Matias Ferreyra, A Mueller, G Allison, W Hedberg, N Macedo, ...
52019
Sero-Detection of Leptospira hardjo in Cattle of Bhaktapur District of Nepal
G Rawal, D Shrestha
42019
Inflammation and novel therapeutic approaches for its management
D HARI KRISHNA, M SRIPAL REDDY, K Rajnarayana, DR Krishna, ...
Indian journal of pharmaceutical sciences 65 (6), 565-575, 2003
42003
Teixobactin: A powerful tool for combating resistant strains
T Rawal, S Butani
Indian J Pharm Sci 78 (6), 697-700, 2016
22016
Epidemiologic characteristics of porcine astrovirus type 3
G Rawal
12019
Description of Herd-Outbreaks Using Killed PRRSV Vaccine with an Attempt to Boost Immune Response
G Rawal, C Rademacher, D Linhares
12018
INHALED FLUTICASONE PROPIONATE DRY POWDER FOR THE EFFECTIVE MANAGEMENT OF ASTHMA
T Rawal, R Mehta, H Koradia, R Mishra, S Butani
Nirma University Journal of Pharmaceutical Sciences 6 (1), 55-68, 2019
2019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20